Skip to Main Content
Services Talent Knowledge
Site Search
Menu

Alert

Our attorneys stay on top of changes in legislation, agency regulations, case law, and industry trends—then craft timely legal alerts to keep clients up to date on legal developments important to their business.

November 21, 2019

House Judiciary Committee Advances MORE Act

On November 20, the House Judiciary Committee voted to advance the Marijuana Opportunity Reinvestment and Expungement Act of 2019 (MORE Act).

The MORE Act recognizes the following:

  • Thirty-three states and the District of Columbia have adopted laws legalizing cannabis for adult use
  • Forty-seven states have reformed cannabis laws despite its federal Schedule I status
  • Continued enforcement of cannabis laws disproportionately impacts people of color
  • Disparate arrest and conviction rates for people of color creates barriers for these individuals to participating in legal cannabis markets by limiting access to loans and capital

While the MORE Act is under jurisdiction of other committees and its passage is questionable, this marks the first time that a House committee has advanced a bill that descheduled marijuana as a class I controlled substance.

Provisions of the MORE Act include:

  • Striking marijuana and tetrahydrocannabinoids (THC) from the Schedule I of controlled substances
  • A retroactive clause that would apply to any offense committed, case pending, or conviction entered before, on, or after the enactment of the MORE Act
  • Requiring the Bureau of Labor Statistics to regularly compile data on individuals who are owners or employees of cannabis businesses
  • Creating the Opportunity Trust Fund to be established and administered by the Small Business Administration
  • Establishing the Cannabis Justice Office within the Office of Justice Programs under the Attorney General, which will administer the Community Reinvestment Grant Program. The program allows eligible entities to administer services such as legal aid, literacy programs, job training, and reentry support to individuals who have been most adversely impacted by the War on Drugs.

If you have any questions regarding the content of this alert, please contact Mary Volcko, project specialist, at mvolcko@barclaydamon.com or another member of the firm’s cannabis team.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

EPA Lists Two New "Forever Chemicals" Under CERCLA

Alerts

NYS Governor Hochul Announces Final RFP for New Certified Community Behavioral Health Clinics

Alerts

The Second Department Affirms Successful Storm in Progress Defense of Slip and Fall Case

Alerts

The New York FY 2025 Budget – CDPAP FIs Under Threat

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Anderson, Beauchamp, Murray, Angeles, Monegro, and Bullock—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Updated Bulletin on Tracking Technologies in the Health Care Industry

We're Growing in DC!

We’re excited to announce Barclay Damon’s combination with Washington DC–based Shapiro, Lifschitz & Schram. SLS’s 10 lawyers, three paralegals, and four administrative staff will join Barclay Damon while maintaining their current office in DC’s central business district. Our clients will benefit from SLS’s corporate, real estate, finance, and construction litigation experience and national energy-industry profile, and their clients from our full range of services.

Read More

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out